What the study found
The study found that D-type chiral mesoporous silica carriers performed best for delivering celecoxib, a poorly water-soluble anti-inflammatory drug. The authors report that these carriers improved drug dissolution and showed the strongest anti-inflammatory effect among the tested systems.
Why the authors say this matters
The authors conclude that the D-type carriers may offer a double benefit: better drug delivery and stronger anti-inflammatory action. They state that this combination could significantly change anti-inflammatory drug treatment.
What the researchers tested
The researchers built two kinds of chiral mesoporous silica systems: xerogels made by a biomimetic method and nanoparticles made by chiral grafting. They loaded celecoxib into these carriers and compared them with a control carrier, then examined carrier-drug interactions, drug crystal form, dissolution, pharmacokinetics, and pharmacodynamics.
What worked and what didn't
All of the chiral carriers formed hydrogen bonds with celecoxib and converted it from a crystalline state to an amorphous state, which improved dissolution compared with the raw drug. D-SX and D-MSNs were reported to be the best carriers, possibly because of their chiral grafted groups, and they showed the best in vivo pharmacokinetic and pharmacodynamic results.
What to keep in mind
The abstract does not describe detailed study limitations or the size of the effects. It also does not provide the full experimental conditions or enough information to judge how broadly the findings apply beyond celecoxib and the carriers tested.
Key points
- D-type chiral mesoporous silica was reported to be the best celecoxib carrier.
- All tested chiral carriers formed hydrogen bonds with the drug.
- The carriers converted celecoxib from crystalline to amorphous form.
- D-SX and D-MSNs showed improved drug dissolution compared with raw celecoxib.
- D-SX and D-MSNs had the strongest in vivo pharmacokinetic and anti-inflammatory results.
Disclosure
- Research title:
- D-type mesoporous silica improved celecoxib delivery and anti-inflammatory effect
- Authors:
- Xue Yan, Lu Wang, Zheng Zhang, Xianbao Shi, Guowei Li
- Institutions:
- Jinzhou Medical University, Jinzhou Medical University, Jinzhou Medical University, Jinzhou Medical University, Jinzhou Medical University
- Publication date:
- 2026-04-06
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.